Un nuevo informe técnico de Bell Integration explora cómo las empresas autónomas desbloquean el ROI a escala
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease